BROKERAGE MOTILAL OSWAL SECURITIES
Sebi's levy order likely to erode Rs 2,000 crore from discount brokers' income, hit client base
Several brokerage companies, including IIFL Securities and Motilal Oswal Financial Services, saw share declines of 3% to 7% due to the regulatory order affecting brokerages, potentially leading to adjustments in zero-payment plans or increased rates.
Broking stocks fall up to 10% after SEBI calls for uniform charges
SEBI instructed MIIs to ensure uniform charges benefiting end clients, with changes effective from October 1, 2024. The circular aims to rectify incorrect disclosures, especially regarding charges collected from end clients by MIIs. MIIs are directed to redesign charge structures and communicate with SEBI for compliance.
Buy Star Health, target price Rs 730.: Motilal Oswal
Star Health and Allied Insurance Company Ltd., incorporated in the year 2005, is a Large Cap company (having a market cap of Rs 31780.89 Crore) operating in Financial Services sector.
Brokerages raise price targets of Vedanta citing multiple positives
The average of revised price targets given by the six brokerages and research firms such as Nuvama, Phillip Capital, IIFL, CLSA, Motilal Oswal Financial Services and Investec, is Rs 536, indicating a 19% upside over Vedanta's closing price of Rs 450.
Motilal Oswal initiates coverage on Mankind Pharma with target price of Rs 2,650
Motilal Oswal initiated coverage on Mankind Pharma with a 'buy' call and target price of Rs 2,650. The company's disruptive strategy in establishing its DF business has made it an industry leader in prescriptions.
F&O stocks to buy today: Escorts, Biocon among top 7 trading ideas for 7 June 2024
“Options data suggests a broader trading range in between 22,200 to 23,500 zones while an immediate range between 22,500 to 23,100 levels,” says Chandan Taparia, Analyst-Derivatives at Motilal Oswal Financial Services Limited.
- Go To Page 1
F&O stocks to buy today: M&M, Voltas among top 8 trading ideas for 6 June
F&O Stocks Today: The Indian market is set to trade higher on positive global cues, Nifty future closed at 22,584 levels with gains of 3.08%. India VIX dropped by 29.28%.
Election stocks to buy: Pick from a buffet of 50+ counters from 5 brokerages
Investors are adjusting portfolios for potential structural reforms under Modi's third term. Sectors like infrastructure, financials, and consumer discretionary are in focus. Brokerages recommend stocks across sectors including SBI, ICICI Bank, L&T, and ONGC for potential gains post-election.
Some Indian brokers impose higher trading margins to withstand election volatility
Some large Indian brokerage firms have asked clients to furnish higher margins against trades this week to limit the risk of default ahead of the results of India's national elections, due on Tuesday.
Election stocks to buy: Over 50 ideas for investors betting their house on Modi's victory
Driven by significant short-covering by Foreign Institutional Investors (FIIs), the Nifty surged approximately 3%, while the Sensex soared by a staggering 2,778 points on Monday morning, following the unexpected exit poll projections of a landslide victory for the NDA. The "Aayega To Modi" slogan became an investing strategy as traders enthusiastically bought Prime Minister Narendra Modi's favored Public Sector Undertakings (PSUs) in entirety.
India Inc exits FY24 on a strong note, clocks double-digit profit growth in Q4
Corporate India saw double-digit growth in net profit and single-digit revenue increase in the March 2024 quarter. Expectations are for healthy growth in the current fiscal year due to peaking interest rates and government policy continuity.
D-Street looks set for Modi rally tomorrow
After the last phase of the election ended on Saturday, exit polls showed the NDA winning with a comfortable majority. Votes will be counted on June 4. Though some exit polls have been inaccurate in the past, investors will take comfort from the fact that most are forecasting a strong show by the Bharatiya Janata Party (BJP).
Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?
Apollo Hospitals Share Price: Apollo Hospitals shares surged by 3.4% during Friday's early trading session, reaching a peak of Rs 5,955. This uptick followed the company's announcement of a significant 77% year-on-year (YoY) increase in its net profit.
R R Kabel shares zoom 6% after posting 20% YoY jump in net profit. Should you invest?
R R Kabel's shares surged 6% on BSE to Rs 1,820.80 after reporting a 20.6% YoY increase in profit after tax to Rs 78.7 crore. The company's revenue rose 15.7% YoY to Rs 1,754 crore, with EBITDA margin at 6.6%.
Tata Steel shares fall 3% post Q4 results. Should you buy, sell or hold?
Tata Steel shares fell 3% after reporting a 64% decline in net profit to Rs 611 crore in Q4FY24, missing D-Street's estimates. Jefferies sees weak results but better than expected, with Motilal Oswal stating revenue at Rs 36,600 crore and ASP affecting EBITDA/t. Jefferies has a 'buy' call with a target price of Rs 200.
Ashok Leyland shares surge 6% after posting 20% YoY increase in Q4 profit. Should you invest?
Ashok Leyland shares surged nearly 6% on BSE to a record high after reporting a 20% YoY increase in its Q4 net profit.
Torrent Pharma, Glenmark Pharma shares jump up to 9% after Q4 results
Shares of Torrent Pharma and Glenmark Pharma surged post Q4 results. Torrent Pharma's net profit jumped 56% YoY while Glenmark Pharma reported increased losses. Motilal Oswal provides target prices for both companies.
Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?
Divi’s Laboratories saw a 5% surge in its shares on the BSE during Monday's trading session, reaching a new 52-week high of Rs 4,335. This rise came as brokerages such as Motilal Oswal and InCred expressed bullish sentiment towards the stock, following the company's impressive performance in Q4, where it reported a 68% year-on-year increase in profits, reaching Rs 538 crore.
ITC share price targets go well beyond Rs 500 after Q4 results. Should you buy, sell or hold?
ITC's Q4 results disappoint investors, shares drop nearly 1% to Rs 437.85. Brokerages raise target prices up to Rs 540. Citi sets target at Rs 515, warns of regulatory impact. Morgan Stanley targets Rs 506, CLSA at Rs 470. Motilal Oswal sees defensive potential, Kotak trims EPS, targets Rs 465. JM Financial holds highest target of Rs 540, emphasizes on cigarette volume growth and capital allocation strategy for rerating.
Sun Pharma shares tumble 5% but brokerages raise target up to Rs 1,785. Should you buy, sell or hold?
In Thursday's trading session on the BSE, shares of Sun Pharmaceutical Industries declined by 5%, reaching the day's low of Rs 1,467. This drop occurred despite the company reporting a 34% year-on-year (YoY) increase in its Q4 profit to Rs 2,654.6 crore, with revenue rising by 10.1% YoY to Rs. 11,813 crore in Q4FY24.
Hot Stocks: Brokerages on Jubilant FoodWorks, Sun Pharma, Nykaa; Motilal upgrades HDFC Life
Top brokerages issue ratings and targets for key stocks: Motilal Oswal upgrades HDFC Life to buy; Jefferies reaffirms buy for Sun Pharma; UBS stays neutral on Nykaa; Jefferies advises hold on Jubilant FoodWorks. Analysts anticipate growth trajectories and address performance factors.
ITC Q4 Preview: Revenue to grow around 3% YoY; margins to contract
Brokerage firms expect that ITC will announce subdued revenue growth for the fourth quarter when it declares its results on May 23. Based on projections from different brokerages, it's anticipated that profits will see a modest 3% year-on-year increase, with the hotels segment expected to perform strongly. In the previous December quarter, ITC recorded a 6% rise in consolidated net profit, amounting to Rs 5,335 crore.
Multibagger defence PSU BEL surges over 9% after Q4 results, earns upgrade from Motilal
BEL shares hit a record high, up 9% after a 30% profit increase and dividend declaration. Brokerages are optimistic about BEL's growth potential, with target prices set by Nomura & Motilal Oswal, citing improved margins & government support for the defence sector.
Oberoi Realty shares jump 9% to new all-time high after 65% increase in net profit. Should you invest?
Oberoi Realty's shares surged by 9% to reach a new 52-week high of Rs 1,712.30 following the company's announcement of a 65% year-on-year (YoY) increase in its Q4 profit, reaching Rs 788 crore.
Vodafone Idea Q4 Preview: Losses to widen 14-19% YoY; 1.5% revenue uptick likely on higher ARPU
Three brokerage firms have forecasted a potential widening of Vodafone Idea's net loss for the March quarter, estimated to range between Rs 7,307.20 crore to Rs 7,680 crore. Additionally, revenue for the quarter is anticipated to hover around Rs 10,690 crore.
Siemens shares surge nearly 9% after brokerages raise price target up to Rs 8,000
Siemens shares soared 8.9% to a new 52-week high of Rs 7,243.60 on BSE following increased target prices by brokerages. The company also approved a scheme to demerge its energy business into a separate listed entity.
Hot Stocks: Brokerages view on AB Capital, Zomato, UPL and Varun Beverages
BofA Securities upheld a buy rating for Varun Beverages, while Jefferies suggested buying Zomato. AB Capital received an Equal Weight rating from Morgan Stanley, and Motilal Oswal advised a neutral stance on UPL.
Cipla Q4 Results Preview: Profit may rise up to 71% YoY on healthy operations
Cipla Q4 Results Preview: As per the combined projections of four brokerages, there's a possibility of the net profit for the fourth quarter surging by as much as 71% year-on-year, alongside an expected 7% year-on-year increase in net sales.
IGL shares surge 7% after Q4 results. Should you invest?
IGL Share Price: Indraprastha Gas (IGL) shares surged 7% after reporting a 16% YoY profit increase to Rs 383 crore in Q4. Despite revenue decline due to lower gas prices, sales volume rose
Load More
